The nuclear receptor NR1D1 has been shown to correlate with MYCN amplification in NB patients82,83 and TFAP4 inhibition leads to differentiation of MYCN-amplified neuroblastoma cells84,85, supporting the validity of the inferred target genes. The gene discussed is MYCN; the disease is neuroblastoma.